182 related articles for article (PubMed ID: 31023624)
41. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
[TBL] [Abstract][Full Text] [Related]
42. TFAP2A regulates nasopharyngeal carcinoma growth and survival by targeting HIF-1α signaling pathway.
Shi D; Xie F; Zhang Y; Tian Y; Chen W; Fu L; Wang J; Guo W; Kang T; Huang W; Deng W
Cancer Prev Res (Phila); 2014 Feb; 7(2):266-77. PubMed ID: 24335623
[TBL] [Abstract][Full Text] [Related]
43. Identification of aurora kinase B and Wee1-like protein kinase as downstream targets of (V600E)B-RAF in melanoma.
Sharma A; Madhunapantula SV; Gowda R; Berg A; Neves RI; Robertson GP
Am J Pathol; 2013 Apr; 182(4):1151-62. PubMed ID: 23416158
[TBL] [Abstract][Full Text] [Related]
44. Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions.
Mills CN; Joshi SS; Niles RM
Mol Cancer; 2009 Nov; 8():104. PubMed ID: 19919690
[TBL] [Abstract][Full Text] [Related]
45. A secondary role for hypoxia and HIF1 in the regulation of (IFNγ-induced) PD-L1 expression in melanoma.
van Duijn A; Willemsen KJ; van Uden NOP; Hoyng L; Erades S; Koster J; Luiten RM; Bakker WJ
Cancer Immunol Immunother; 2022 Mar; 71(3):529-540. PubMed ID: 34268602
[TBL] [Abstract][Full Text] [Related]
46. STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells.
Pawlus MR; Wang L; Hu CJ
Oncogene; 2014 Mar; 33(13):1670-9. PubMed ID: 23604114
[TBL] [Abstract][Full Text] [Related]
47. Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic
Cenigaonandia-Campillo A; Serna-Blasco R; Gómez-Ocabo L; Solanes-Casado S; Baños-Herraiz N; Puerto-Nevado LD; Cañas JA; Aceñero MJ; García-Foncillas J; Aguilera Ó
Theranostics; 2021; 11(8):3595-3606. PubMed ID: 33664850
[No Abstract] [Full Text] [Related]
48. Silencing Ku80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo.
Nimura Y; Kawata T; Uzawa K; Okamura J; Liu C; Saito M; Shimada H; Seki N; Nakagawara A; Ito H; Ochiai T; Tanzawa H
Int J Oncol; 2007 Jun; 30(6):1477-84. PubMed ID: 17487369
[TBL] [Abstract][Full Text] [Related]
49. Fructose-coated Angstrom silver inhibits osteosarcoma growth and metastasis via promoting ROS-dependent apoptosis through the alteration of glucose metabolism by inhibiting PDK.
Hu XK; Rao SS; Tan YJ; Yin H; Luo MJ; Wang ZX; Zhou JH; Hong CG; Luo ZW; Du W; Wu B; Yan ZQ; He ZH; Liu ZZ; Cao J; Wang Y; Situ WY; Liu HM; Huang J; Wang YY; Xia K; Qian YX; Zhang Y; Yue T; Liu YW; Zhang HQ; Tang SY; Chen CY; Xie H
Theranostics; 2020; 10(17):7710-7729. PubMed ID: 32685015
[TBL] [Abstract][Full Text] [Related]
50. RPS3 regulates melanoma cell growth and apoptosis by targeting Cyto C/Ca2+/MICU1 dependent mitochondrial signaling.
Tian Y; Qin L; Qiu H; Shi D; Sun R; Li W; Liu T; Wang J; Xu T; Guo W; Kang T; Huang W; Wang G; Deng W
Oncotarget; 2015 Oct; 6(30):29614-25. PubMed ID: 26336993
[TBL] [Abstract][Full Text] [Related]
51. Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance.
Ma Q; Li P; Xu M; Yin J; Su Z; Li W; Zhang J
J Exp Clin Cancer Res; 2012 Nov; 31(1):99. PubMed ID: 23181744
[TBL] [Abstract][Full Text] [Related]
52. Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma.
Lu H; Lu Y; Xie Y; Qiu S; Li X; Fan Z
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578313
[TBL] [Abstract][Full Text] [Related]
53. Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth.
Qin L; Tian Y; Yu Z; Shi D; Wang J; Zhang C; Peng R; Chen X; Liu C; Chen Y; Huang W; Deng W
Oncotarget; 2016 Jan; 7(2):1395-407. PubMed ID: 26593251
[TBL] [Abstract][Full Text] [Related]
54. Pyruvate dehydrogenase kinase 4-mediated metabolic reprogramming is involved in rituximab resistance in diffuse large B-cell lymphoma by affecting the expression of MS4A1/CD20.
Jiang D; Mo Q; Sun X; Wang X; Dong M; Zhang G; Chen F; Zhao Q
Cancer Sci; 2021 Sep; 112(9):3585-3597. PubMed ID: 34252986
[TBL] [Abstract][Full Text] [Related]
55. Ku80 correlates with neoadjuvant chemotherapy resistance in human lung adenocarcinoma, but reduces cisplatin/pemetrexed-induced apoptosis in A549 cells.
Shang B; Jia Y; Chen G; Wang Z
Respir Res; 2017 Apr; 18(1):56. PubMed ID: 28399858
[TBL] [Abstract][Full Text] [Related]
56. BCL-X
Trisciuoglio D; Tupone MG; Desideri M; Di Martile M; Gabellini C; Buglioni S; Pallocca M; Alessandrini G; D'Aguanno S; Del Bufalo D
Cell Death Dis; 2017 Dec; 8(12):3216. PubMed ID: 29238043
[TBL] [Abstract][Full Text] [Related]
57. Inhibiting MT2-TFE3-dependent autophagy enhances melatonin-induced apoptosis in tongue squamous cell carcinoma.
Fan T; Pi H; Li M; Ren Z; He Z; Zhu F; Tian L; Tu M; Xie J; Liu M; Li Y; Tan M; Li G; Qing W; Reiter RJ; Yu Z; Wu H; Zhou Z
J Pineal Res; 2018 Mar; 64(2):. PubMed ID: 29149494
[TBL] [Abstract][Full Text] [Related]
58. Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1.
Kumar P; Gullberg U; Olsson I; Ajore R
PLoS One; 2015; 10(5):e0123725. PubMed ID: 25974097
[TBL] [Abstract][Full Text] [Related]
59. Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditions.
Liu M; Du K; Fu Z; Zhang S; Wu X
Med Oncol; 2015 Jan; 32(1):394. PubMed ID: 25432699
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma.
Haak AJ; Appleton KM; Lisabeth EM; Misek SA; Ji Y; Wade SM; Bell JL; Rockwell CE; Airik M; Krook MA; Larsen SD; Verhaegen M; Lawlor ER; Neubig RR
Mol Cancer Ther; 2017 Jan; 16(1):193-204. PubMed ID: 27837031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
